long intergenic non-protein coding RNA 2705Genealiases: []
Q-omics provides the consensus-scored LINC02705 profile across patient tissues and cancer cell-line models. LINC02705 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in SKCM. Among the 18 cancer types available for tumor–normal comparison, LINC02705 is differentially expressed in 6, with the highest sampling consensus in KIRC. Additionally, LINC02705 RNA expression shows 15,289 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight SKCM, KIRC, and GBM as cancer lineages where LINC02705 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02705 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02705 survival associations across molecular data types. LINC02705 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02705 RNA expression–survival associations across cancer types. High LINC02705 expression shows unfavorable associations in LGG, LAML, KICH and DLBC, but favorable associations in SKCM and READ. The SKCM Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify SKCM as the clearest survival context for LINC02705 RNA expression.
This table summarizes LINC02705 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 6. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02705. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02705 shows lower tumor expression in BRCA, LIHC, LUSC and COAD and higher tumor expression in KIRC and HNSC. The KIRC box plot shows higher LINC02705 RNA expression in tumor versus normal tissue (log2 FC = +0.339, t-test p < 0.001).
This table shows molecular features associated with LINC02705 in patient tissues and cancer cell lines. In patient samples, LINC02705 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
